⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL29193468 | 0.95 | — | — | |
| SCHEMBL1736341 | 0.94 | ALDH1A1 (0.40) | — | |
| SCHEMBL30 | 0.94 | — | — | |
| SCHEMBL124190 | 0.94 | — | — | |
| SCHEMBL742858 | 0.89 | — | — | |
| Bromide SCHEMBL328981 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL5047658 | 0.89 | ALDH1A1 (0.36) | — | |
| Water SCHEMBL20920097 | 0.89 | ALDH1A1 (0.36) | — | |
| Fluoride SCHEMBL22345959 | 0.89 | ALDH1A1 (0.36) | — | |
| SCHEMBL3466974 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117597368-A | Curable composition and cured product | 迪睿合株式会社 | 2024-02-23 | — | — | CN | disclosed |
| US-20110282044-A1 | PROCESS FOR SYNTHESIZING OLIGONUCLEOTIDE PHOSPHATE DERIVATIVES | ALNYLAM PHARMACEUTICALS (US) | 2011-11-17 | — | — | US | disclosed |
| WO-2011028218-A1 | PROCESS FOR TRIPHOSPHATE OLIGONUCLEOTIDE SYNTHESIS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2011-03-10 | — | — | WO | disclosed |
| EP-0701611-B1 | HUMAN METABOTROPIC GLUTAMATE RECEPTORS, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF | MERCK & CO INC (US) | 2010-02-17 | — | — | EP | disclosed |
| US-6485919-B1 | Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof | MERCK & CO., INC. | 2002-11-26 | — | — | US | disclosed |
| EP-1001816-A4 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-07-17 | — | — | EP | disclosed |
| US-6414139-B1 | MIXTURE WITH GAS OR GAS PRECURSOR; DIAGNOSTIC IMAGING; ULTRASOUND AND COMPUTER AXIAL TOMOGRAPHY | IMARX THERAPEUTICS, INC. | 2002-07-02 | — | — | US | disclosed |
| US-6413764-B1 | CELL LINE STABLY TRANSFORMED WITH HETEROLOGOUS NUCLEIC ACID; FOR PRODUCTION OF RECEPTORS; DRUG SCREENING | MERCK & CO., INC. | 2002-07-02 | — | — | US | disclosed |
| US-6362009-B1 | CAPTURING A SUBSTRATE ON SOLID SUPPORT AND ACTIVATINGSUBSTRATE TO REACT WITH REAGENT WITH WHICH UNACTIVATED SUBSTRATE DOES NOT REACT; REACTING ACTIVATED SUBSTRATE ON SOLID PHASE WITH REAGENT TO GIVE AN ADDITION PRODUCT | MERCK & CO., INC. | 2002-03-26 | — | — | US | disclosed |
| US-6362316-B1 | USED TO IDENTIFY AND CHARACTERIZE COMPOUNDS WHICH AFFECT THE FUNCTION OF SUCH RECEPTOR SUBTYPE, E.G., AGONISTS, ANTAGONISTS, AND MODULATORS OF GLUTAMATE RECEPTOR FUNCTION | MERCK & CO., INC. | 2002-03-26 | — | — | US | disclosed |
| US-5807689-A | BIOANALYSIS | SIBIA NEUROSCIENCES, INC. (US) | 1998-09-15 | — | — | US | disclosed |
| WO-1998023298-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-04 | — | — | WO | disclosed |
| EP-0831927-A1 | STABILIZED COMPOSITIONS OF FLUORINATED AMPHIPHILES AS CONTRAST AGENTS FOR ULTRASOUND | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1998009600-A2 | NOVEL SILICON AMPHIPHILIC COMPOUNDS AND THE USE THEREOF | IMARX PHARMACEUTICAL CORP. (US) | 1998-03-12 | — | — | WO | disclosed |
| EP-0815227-A1 | HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF | Sibia Neurosciences, Inc. (US) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996039197-A1 | STABILIZED COMPOSITIONS OF FLUORINATED AMPHIPHILES AS CONTRAST AGENTS FOR ULTRASOUND | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996029404-A1 | HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6 | SIBIA NEUROSCIENCES, INC. (US) | 1996-09-26 | — | — | WO | disclosed |
| US-5521297-A | Nucleic acids encoding human metabotropic glutamate receptors | SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES (US) | 1996-05-28 | — | — | US | disclosed |
| EP-0701611-A1 | HUMAN METABOTROPIC GLUTAMATE RECEPTORS, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF | SIBIA NEUROSCIENCES, INC. (US) | 1996-03-20 | — | — | EP | disclosed |
| WO-1994029449-A1 | HUMAN METABOTROPIC GLUTAMATE RECEPTORS, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF | THE SALK INSTITUTE BIOTECHNOLOGY/INDUSTRIAL ASSOCIATES, INC. (US) | 1994-12-22 | — | — | WO | disclosed |